COMMUNIQUÉS West-GlobeNewswire

Samumed Announces Multiple Presentations at the European League Against Rheumatism (EULAR) 2018 Annual Congress
08/06/2018
SAN DIEGO, June 08, 2018 (GLOBE NEWSWIRE) -- Samumed, LLC, announced today that it will present clinical and preclinical data on two of the company’s investigational drugs, SM04690, for the treatment of osteoarthritis ( [...]
Selecta Biosciences to Present Data from Ongoing Phase 2 Trial of SEL-212, in Development for Chronic Severe Gout, at EULAR 2018
08/06/2018
WATERTOWN, Mass., June 08, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq:SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by mitigating [...]
Incysus Therapeutics Scientific Co-Founder Lawrence Lamb, PhD to Present at 8th International Gamma-Delta T Cell Conference
08/06/2018
Symposium Title: “ Targeting of chemotherapy-induced NKG2DL by localized repetitive γδ T cell infusions: a rational therapeutic design for elimination of minimal residual primary high grade gliomas” NEW YORK, June 08, [...]
Biohit Oyj: Managers' Transactions
08/06/2018
Biohit Oyj: Managers' Transactions BIOHIT Oyj MANAGERS’ TRANSACTIONS 8 JUNE 2018 P.M. 2.40 Biohit Oyj: Managers' Transactions Person subject to the notification requirement Name: Interlab Oy Position: Closely Associated [...]
Solon Eiendom ASA : Primary insider notification
08/06/2018
(Oslo, Norway, June 08, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg has today through his wholly owned company Skøien AS bought 40.000 shares at a price of NOK 30.0091 and through his wholly owned company [...]
Terveystalo Plc: Changes in the Composition of Shareholders' Nomination Board
08/06/2018
Terveystalo Plc Stock Exchange release 8 June 2018 at 14:35 p.m. EEST The Helsinki Deaconess Institute has appointed Laura Raitio as its new representative for Terveystalo's Shareholders' Nomination Board, replacing [...]
Surface Oncology to Present at Goldman Sachs 39th Annual Global Healthcare Conference
08/06/2018
CAMBRIDGE, Mass., June 08, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today [...]
Assembly Biosciences Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
08/06/2018
INDIANAPOLIS and SAN FRANCISCO, June 08, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB) a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis [...]
G1 Therapeutics Announces Appointment of New Members to the Board of Directors
08/06/2018
RESEARCH TRIANGLE PARK, N.C., June 08, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq:GTHX), a clinical-stage oncology company, today announced that Cynthia Schwalm and Willie Deese have been appointed to its [...]
Fennec Announces Results of Annual Meeting
08/06/2018
RESEARCH TRIANGLE PARK, N.C., June 08, 2018 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated April [...]
Amicus Therapeutics Appoints President and COO Bradley L. Campbell to Board of Directors
08/06/2018
Directors Donald J. Hayden, Jr. and Craig A. Wheeler Re-Elected CRANBURY, N.J., June 08, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company focused on discovering, developing and [...]
XORTX Announces Filing of FDA pre-IND Meeting Request Letter
08/06/2018
CALGARY, Alberta, June 08, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE:XRX) (OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat [...]
Emergent BioSolutions to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference
08/06/2018
GAITHERSBURG, Md., June 08, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that a member of the company’s senior management team will present a corporate overview and discuss recent [...]
Solon Eiendom ASA : LAST DAY OF SUBSCRIPTION PERIOD IN THE SUBSEQUENT OFFERING
08/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]
Oasmia Pharmaceutical AB (publ) Year-end report for the financial year May 1, 2017 – April 30, 2018
08/06/2018
FOURTH QUARTER February 1, 2018 – April 30, 2018 Consolidated net sales amounted to TSEK 843 compared to TSEK 44 in the fourth quarter the previous year Operating loss was TSEK 28,017 compared to TSEK 37,411 in the [...]
Shire plc : Rule 2.9 Announcement
08/06/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 8 June 2018 Shire [...]
Celixir announces US FDA approval of the IND application for cell therapy Heartcel
08/06/2018
Celixir announces US FDA approval of the IND application for cell therapy Heartcel TM FDA IND and UK MHRA CTA approval both achieved in H1 2018 Potentially pivotal heart failure trial of up to 250 patients in the UK and [...]
Midatech Pharma US enrols first patient in Gelclair trial in stem cell transplant
08/06/2018
8 June 2018 Midatech Pharma PLC (“Midatech”, “Company” or “Group”) Midatech Pharma US enrols first patient in Gelclair® trial in stem cell transplant Patients now being enrolled at the Dana-Farber/Brigham and Women’s [...]
IBA SA : IBA Signs Contract to Install Cyclone® 70 System in Arizona, USA
08/06/2018
IBA Signs Contract to Install Cyclone ® 70 System in Arizona, USA Cyclotron to be dedicated to the production of radiopharmaceuticals for diagnosing and treating critical illnesses worldwide Louvain-la-Neuve, Belgium, [...]

Pages